Omeros (OMER)
(Delayed Data from NSDQ)
$3.81 USD
-0.25 (-6.16%)
Updated Jun 4, 2024 04:00 PM ET
After-Market: $3.80 -0.01 (-0.26%) 7:58 PM ET
4-Sell of 5 4
C Value A Growth B Momentum A VGM
Brokerage Reports
Omeros Corporation [OMER]
Reports for Purchase
Showing records 421 - 423 ( 423 total )
Company: Omeros Corporation
Industry: Medical - Products
Q2 Financials Uneventful; However, In Our View Phase 3 Clinical Data Release In Q4 Could Result In Significant Upside.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Omeros Corporation
Industry: Medical - Products
Q1 Financials Uneventful; However, We Believe Clinical Data In H2 2010 Could Result In Significant Upside.
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L
Company: Omeros Corporation
Industry: Medical - Products
2009 Financials Uneventful; However, We Believe Additional Clinical Data In 2010 Could Result In Significant Upside
Provider: WEDBUSH SECURITIES INC.
Analyst: MOUSSATOS L